This site is intended for UK healthcare professionals only. If you are not a UK healthcare professional,
please visit our dedicated site for more information at www.beigene.co.uk
ONE BTK INHIBITOR: MANY POSSIBILITIES
The changing landscape of Waldenström’s Macroglobulinemia (WM) in Scotland
‘The changing landscape of Waldenström’s Macroglobulinemia (WM) in Scotland’ was a live virtual meeting.
agenda
Discussion topic
Discussion Lead
Welcome
Dr Pam McKay
The history and background of WM in Scotland
Dr Pam McKay
Current treatments: BSH guidelines
Dr Dima El-Sharkawi
An in-depth look at the ASPEN study
Dr Shirley D’Sa and Dr Roger OwenDr Jaimal Kothari
Practical considerations of BRUKINSA®▼
Dr Jaimal Kothari
Panel discussion
Dr McKay, Dr El-Sharkawi ad Dr D’Sa
Close
Dr Pam McKay
Recording
The Changing Landscape of WM in Scotland with Dr Pam McKay
Date of preparation: November 2022. 1122-BRU-PRC-067
Current Treatments: BSH Guidelines with Dr Dima El-Sharkawi
Date of preparation: November 2022. 1122-BRU-PRC-097
An In-Depth Look at the ASPEN Study with Dr Roger Owen and Dr Shirley D’Sa
Date of preparation: November 2022. 1122-BRU-PRC-100
Practical Considerations of Brukinsa with Dr Jaimal Kothari
Date of preparation: November 2022. 1122-BRU-PRC-102
Panel Discussion with Dr Pam McKay, Dr Shirley D’Sa and Dr Dima El-Sharkawi
Date of preparation: December 2022. 1122-BRU-PRC-065
Select an indication to learn more about BRUKINSA:
